These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29348846)

  • 21. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
    Mori T; Nishizawa S; Hirohashi Y; Torigoe T; Tamura Y; Takahashi A; Kochin V; Fujii R; Kondo T; Greene MI; Hara I; Sato N
    Exp Mol Pathol; 2012 Feb; 92(1):27-32. PubMed ID: 22001602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to
    Severino PF; Silva M; Carrascal M; Malagolini N; Chiricolo M; Venturi G; Astolfi A; Catera M; Videira PA; Dall'Olio F
    Oncotarget; 2017 Aug; 8(33):54506-54517. PubMed ID: 28903359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin.
    Chung LY; Tang SJ; Wu YC; Sun GH; Liu HY; Sun KH
    Oncotarget; 2015 Mar; 6(7):4936-52. PubMed ID: 25669973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
    McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
    Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response.
    Yamashita M; Hirohashi Y; Torigoe T; Kusumoto H; Murai A; Imagawa T; Sato N
    PLoS One; 2016; 11(1):e0146501. PubMed ID: 26751205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480.
    Butler SJ; Richardson L; Farias N; Morrison J; Coomber BL
    Biochem Biophys Res Commun; 2017 Aug; 490(1):29-35. PubMed ID: 28576498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.
    Yamada R; Takahashi A; Torigoe T; Morita R; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Watarai K; Kondo T; Hirohashi Y; Sato N
    Tissue Antigens; 2013 Jun; 81(6):428-34. PubMed ID: 23574628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cells, colorectal cancer and cancer stem cell markers correlations.
    Cherciu I; Bărbălan A; Pirici D; Mărgăritescu C; Săftoiu A
    Curr Health Sci J; 2014; 40(3):153-61. PubMed ID: 25729599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
    Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
    Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
    Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research progression in colorectal cancer stem cells].
    Wu TY; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
    Maccalli C; Parmiani G; Ferrone S
    Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
    Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
    Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance.
    Ghatak S; Hascall VC; Karamanos N; Markwald RR; Misra S
    Front Oncol; 2022; 12():906415. PubMed ID: 35982950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation.
    Bhatlekar S; Viswanathan V; Fields JZ; Boman BM
    J Cell Physiol; 2018 Feb; 233(2):727-735. PubMed ID: 28464221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
    Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
    J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.